Summit CityMD Announces Key Executive Appointments
SUMMIT CITYMD ANNOUNCES KEY EXECUTIVE APPOINTMENTS
Establishes Regional Leaders for Strategic Growth; Promotes Quality Leader;
Appoints Head of Diversity, Equity & Inclusion (DEI)
NEW YORK AND BERKELEY HEIGHTS, NJ – October 7, 2020 – Summit CityMD, the first-of-its-kind health care entity created by the merger of Summit Medical Group and CityMD, today announced a new regional approach to growing and managing the organization along with a commitment to Diversity, Equity & Inclusion (DEI).
A Regional Approach to Management
“Today, we are moving to a regional management approach to continue our strategic growth in the New York metropolitan area,” said Jeffrey Le Benger, MD, CEO, Summit CityMD. “All clinical operations and leadership, including urgent care and multi-specialty practices, will become part of their respective regions under the following leadership, who are all proven clinical leaders on both sides of our organization.”
New York region:
- Vincent “Jim” Campasano, MD, Chief Operating Officer, New York Region
- Dan Frogel, MD, Chief Medical Officer, New York Region
New Jersey region:
- Jennifer Marchitto, Chief Operating Officer, New Jersey Region
- Jack Cappitelli, MD, Chief Medical Officer, New Jersey Region
The regional COOs will oversee all urgent care and physician practice operations in their respective regions. They will report to Summit CityMD President Rob Connor. The regional CMOs will oversee the medical care model and report to Summit CityMD CMO Kerry LeBenger, MD.
“I am certain this regional approach will help us quickly add physician practices in New York while expanding our comprehensive care model in New Jersey. We are fortunate to have such accomplished leaders to take us there,” Le Benger continued.
Focus on Quality
Additionally, with an uncompromising focus on quality initiatives, Summit CityMD promoted Ashish Parikh, MD as its Chief Quality Officer. Dr. Parikh is already a proven leader in driving high quality clinical outcomes, and his elevated role will be a critical piece as Summit CityMD builds out its integrated approach to care across the tri-state area.
A Commitment to Diversity, Equity and Inclusion (DEI)
The creation of a DEI program along with the appointment of Natalie Thigpen to the newly created role of Senior Vice President, DEI, represents a meaningful commitment by Summit CityMD to support the advancement of DEI as a shared responsibility and strategic business priority that will play an important role in the organization’s success.
Thigpen will be responsible for developing, launching, and running the DEI program for Summit CityMD. She will initially focus on three broad areas: A talent acquisition model for providers and managers; training programs on diversity, equity, inclusion, development, and retention; and, ensuring awareness and inclusion in the patient experience. These efforts, along with the company’s continual work to create a uniquely accessible comprehensive care delivery model, are closely tied to the company’s mission to build healthier, kinder communities.
About Summit CityMD
Established in 2019 as a result of the merger between Summit Medical Group, one of the premier physician-governed multispecialty medical groups in the country, and CityMD, the leading urgent care provider in the New York metro area, Summit CityMD provides patients an exceptional, seamless experience across a full spectrum of high-quality primary, specialty, and urgent care. The first integrated delivery of care network of its kind, the combined organization has more than 1,600 providers, approximately 8,000 employees and nearly 200 locations in New Jersey and New York. For more information, visit Summit-CityMD.com.
For more information about CityMD and a list of locations, please visit CityMD.com.
Follow CityMD on Facebook facebook.com/CityMD, Twitter @CityMD, and Instagram @CityMD.
For more information about Summit Medical Group, please visit summitmedicalgroup.com.
Follow Summit Medical Group on Facebook facebook.com/summitmedicalnj/, Twitter @SummitMedicalNJ, and Instagram @SummitMedicalNJ.
NJBIZ Conversations with Summit CityMD Jeffrey Le Benger, MD, CEO
In the latest online video segment of “NJBIZ Conversations,” Editor Jeff Kanige spoke to Summit CityMD Chief Executive Officer Dr. Jeffrey Le Benger about the first year of the merger, delivering care during the COVID-19 pandemic and the company’s expansion plans. “We are going to create a health care delivery model in the New York metropolitan area that is nowhere else in the country,” LeBenger said. “We take care of almost 800,000 unique patients a year, we run between the entire company 6 million visits a year. We expect to put on major hubs in the New York metropolitan area. Long Island, as well as Westchester County. We’re going to continue to grow.”
Coalition for Physician Well-Being Webinar
James Korman, PsyD, Fellow A-CBT
Service Line Chief of Behavioral Health & Wellness
Summit Medical Group
Developing Community thru the Virtual Physician Lounge
Coalition for Physician Well-Being Webinar
Friday, September 18, 2020
12:00 – 1:00 pm (Eastern)
Learn how Summit CityMD leveraged an internal social media platform to allow providers to discuss cases, ask general medical questions, seek referrals, praise a colleague, post surveys and provide each other support. Also, see how this medium became a critical connection and support avenue during the on-going COVID-19 pandemic. Discussion of the process of obtaining approval for the program, recruiting physician administrators, obtaining buy-in, rates of utilization and lessons learned will also be highlighted.
Please register for the webinar via the following link: Monthly Coalition Webinar
Summit CityMD Paves Way to New Care Delivery Model
One year after the merger between Summit Medical Group and CityMD, CEO Dr. Jeffrey Le Benger tells HealthLeaders about the accomplishments of the joint organization during an extraordinary period and how Summit CityMD's combined primary care and urgent care model aims to enable seamless care for patients with lower costs and greater outcomes. Click here to read the full article.
Rebecca Levy - NJBIZ General Counsel of the Year Finalist
NJBIZ, New Jersey’s leading business news publication, will hold its first virtual awards ceremony on August 12 to honor the winners of their General Counsel Awards which recognizes legal leaders who have made the in-house practice of law their career focus. This year, Summit CityMD's Chief Legal and Administrative Officer and General Counsel, Becky Levy, has landed as a finalist among an elite group of seven nominees in the health care organization category. Following an open nomination process, submissions were evaluated by an independent panel of judges who evaluated career accomplishments, organizational contributions, legal victories, and professional service.
Turning to Telemedicine
The COVID-19 pandemic made telemedicine an essential element of care delivery. To help make it easy for patients to seek care while limiting potential exposure to the coronavirus, SMG rapidly expanded its ability to offer telemedicine visits with providers in primary care and across specialties. Since launching the expanded telemedicine platform, approximately 90 percent of SMG’s cardiology visits have been through a video or telephone interaction. Through a guest article for Horizon Blue Cross Blue Shield of New Jersey’s Health News, SMG’s Dr. Andrew Beamer, Chair of Cardiology, shares how telemedicine was successfully implemented at SMG and why virtual visits will continue to be an integral part of health care delivery.
Sharing Expertise: AMGA Roundtable-Wellness Initiatives at Summit CityMD
On Wednesday, April 15, Summit Medical Group Chief of Behavioral Health and Wellness, Dr. James Korman, along with Senior Vice President of Medical Affairs and Quality, Dr. Ashish Parikh, hosted a roundtable for the Chief Medical Officers Council and Quality Council of the American Medical Group Association (AMGA) on Wellness Initiatives for Providers and Staff During the COVID-19 Crisis. Dr. Parikh moderated while Dr. Korman presented the notable work Summit Medical Group is doing to maintain the well-being of our staff and providers during this difficult time. The presentation—met with great acclaim and later shared with all AMGA providers—included information on our behavioral health services and wellness program initiatives as well as strategies in place to address current stressors.
Physician Leadership and Innovation During Coronavirus Crisis
Despite being deeply entangled in the biggest health care crisis of our time, our doctors continue to lead the way, not only guiding patients and staff through this difficult period but also sharing our health care delivery successes with others to help address the needs of a broader health system.
On March 26, the National Association of ACOs (NAACOs) hosted Webinar Today: New Telehealth Flexibilities, a panel presentation where panelists, including our own Dr. Ashish Parikh, discussed technology’s critical role in direct patient care and how providers are implementing new digital processes to combat the coronavirus crisis. In his presentation, Dr. Parikh covered details such as expanded telehealth benefits under the Trump administration and SMG’s rapid adoption of virtual visits, which has the potential to minimize the burden on emergency departments and hospital systems. The following day, Dr. Parikh presented on the role medical groups can play in supporting the healthcare system during this pandemic alongside Scott Hines, MD, Crystal Run Healthcare's Chief Quality Officer, on an American Medical Group Association (AMGA) Quality Council panel focused on medical group response to COVID-19.
We’re beyond proud that even during such a chaotic and uncertain time, especially for our industry, our organization and its devoted employees do not seem to miss a beat.
“The Show Must Go On!”: Arcadia and Its Customers Create a Virtual Conference to Demonstrate How to Make Value-based Care Profitable
After cancelation of largest healthcare technology show, analytics leader plans for customers to speak about improved performance in value-based payment models
Burlington, Mass.—March 10, 2020—Arcadia (arcadia.io), a widely-recognized leader in population health management, today announced the launch of “Arcadia’s Value-Based Care Leadership Series” to provide a virtual conference to ensure HIMSS attendees, as well as others, will still be able to attend the six general education sessions from their notable and innovative clients. This virtual conference will feature presentations by the leaders in value-based care who were scheduled to present at HIMSS20.
“Arcadia is proud that our innovative provider clients were recognized by HIMSS to deliver sessions about how they’ve successfully navigated value-based payment models,” said Arcadia chief executive officer Sean Carroll. “These customers have agreed to provide their experiences and successes, in a virtual format, over the next few weeks because they are eager to share with peers how to overcome the uncertainty of transitioning from volume-based to value-based care. The honors they were recognized for by HIMSS highlight Arcadia’s dedication to partnering with them and helping to succeed in the evolution of healthcare delivery.”
The virtual conference will feature seven separate webinars and will kick off on Wednesday, March 11 at 11:15 am Eastern with a lunch-and-learn webinar featuring Dr. John Halamka of the Mayo Clinic. Dr. Halamka, who is known for his work at the forefront of technology-enabled care delivery and serves as president of Mayo Clinic Platform, a digital health initiative designed to transform care delivery, will discuss his thoughts on the state of digital health.
Following the initial webinar on March 11, Arcadia will conduct a new webinar almost every week throughout March, April and May. Healthcare leaders will share their strategies in achieving success and the importance of data and analytics technology in the transition to value-based payment models. The following provides additional information about the virtual lunch-and-learn as well as upcoming webinars. For virtual session dates and times, and to register, please visit https://www.arcadia.io/about-arcadia/vbc-leadership-series/.
- Summit Medical Group will deliver two webinars:
- Drs. Jamie L. Reedy and Amina A. Ahmed will present “Using Analytics to Drive Patient-Centered Post-Acute Care” which will demonstrate how Summit has achieved success by implementing technology to support care coordination and monitor performance across care settings in order to reduce their year-over-year length of stay metrics for skilled nursing facilities.
- Drs. Jamie L. Reedy and Ashish D. Parikh will present “Commercial Risk: Getting off to a Successful Start” which will illustrate how Summit has aligned incentives with a data-driven education program for both clinicians and staff to deliver patient-centric, high quality care while succeeding in seven value-based contracts.
- Community Health Plan of Washington will present “Capturing SDoH Data Across Community Health Centers” which will address how to engage and partner with providers to capture and work with SDoH data to enable community partners and community health centers to mobilize resources.
- Central Georgia Health Network will present “Helping PCPs Transition to New Payment Models” which will explain how they prepared a large, diverse clinically integrated network to deal with changing payment models.
- MaineHealth Accountable Care Organization will present “Tackling Emergency Department Utilization with Predictive Analytics” to showcase how emergency departments (EDs) can reduce unnecessary utilization with predictive analytics and will look at how the organization launched REDUCE (Reducing ED Utilization: A Collaborative Endeavor) to address the high rates of ED utilization (one of the highest in the nation) in 10 regions in Maine.
- AMITA Health will present “Rewarding Value: Realigning Physician Compensation” which will look at how AMITA has used analytics and behavioral economics to incentivize high quality and efficient care. In addition, the webinar will review strategies for engaging physicians in value-based transformation and the importance of clinical integration as a vehicle for crafting virtually integrated delivery systems.
Arcadia (arcadia.io) is the only healthcare data and software company dedicated to healthcare organizations achieving financial success in value-based care. We work with health systems, providers, payers and life science companies positioning themselves to win in value-based care, including some of the largest, most complex and influential health systems in the country. Through our purpose-built population health platform our customers consistently overperform industry average outcomes by reducing medical expenses, improving risk coding accuracy, and improving quality and patient health outcomes. Our software continuously aggregates and curates the highest quality, most complete and up-to-date data foundation; provides relevant, timely and predictive analytics; and enables action through care management tools and in-workflow insights that present at the point of care. Arcadia has off-the-shelf integration technology for more than 50 different physical and behavioral health EHR vendors, powered by machine learning that combs through variations in over 77 million longitudinal patient records across clinical, claims, social determinants of health and operational data sources. Founded in 2002, Arcadia is headquartered outside Boston in Burlington, MA, with offices in Seattle, Pittsburgh, Chicago, and Rockford, IL. Arcadia has been recognized as the leading vendor by Forrester, IDC, Chilmark and KLAS, including being awarded Best in KLAS for Value-Based Care Managed Services in 2019 and again in 2020.
Nicole Rodriguez, Senior Account Director, Amendola Communications for Arcadia
Catheter ablation with renal denervation may eliminate AF at 12 months
Renal denervation with catheter ablation in patients with paroxysmal atrial fibrillation and hypertension significantly increased the likelihood of freedom from AF at 12 months compared with catheter ablation alone, according to results of the ERADICATE-AF trial published in JAMA.
The publication confirms findings previously presented at the Heart Rhythm Society Annual Scientific Sessions in 2019.
“The results of this study provide strong proof that renal denervation can augment the results of standard catheter ablation for AF and suggest that a strategy of incorporating autonomic modulation is a useful approach to arrhythmia control independent of direct targeting of cardiac tissue,” Jonathan S. Steinberg, MD, FHRS, adjunct professor of medicine at the University of Rochester School of Medicine and Dentistry and director of SMG Arrhythmia Services at Summit Medical Group of New Jersey, told Healio.
AF and hypertension
Researchers analyzed data from 302 patients (median age, 60 years; 60% men) with a history of symptomatic paroxysmal AF, a history of clinically significant hypertension and plans to undergo ablation. Patients were assigned catheter ablation using pulmonary vein isolation alone (n = 148) or with renal denervation (n = 154).
The primary endpoint was freedom from AF recurrence at 12 months without taking antiarrhythmic drugs. Several secondary endpoints were assessed including mean systolic BP and procedural complications.
Patients attended follow-up visits at 1 month, 3 months, 6 months, 9 months and 12 months. Treatment failure was defined as the initiation of antiarrhythmic drugs or repeat ablation procedures.
The majority of patients (93.7%) completed the trial, and all patients successfully underwent assigned procedures.
At 12 months, freedom from AF, atrial flutter or atrial tachycardia occurred in 56.5% of patients assigned pulmonary vein isolation alone vs. 72.1% of those assigned pulmonary vein isolation with renal denervation (HR = 0.57; 95% CI, 0.38-0.85).
From baseline to 12 months, mean systolic BP decreased from 151 mm Hg to 147 mm Hg in patients assigned pulmonary vein isolation only. By contrast, patients assigned pulmonary vein isolation plus renal denervation had a decline in systolic BP from 150 mm Hg to 135 mm Hg (between-group difference = 13 mm Hg, 95% CI, 15 to 11; P < .001).
Procedural complications occurred in 4.7% of patients in the isolation-only group vs. 4.5% of those in the renal denervation group (absolute risk difference = 0.1%; 95% CI, 4 to 4.4; P > .99).
“We have designed additional trials to expand the potential universe of patients who may be eligible to the approach used in this trial,” Steinberg said in an interview. “Our highest priority are patients with persistent AF as well as controlled hypertension or absence of hypertension.”
Steinberg added that the absence of a sham-controlled group in this trial does not detract from the findings “because patients were fully sedated and completely unaware of which procedure was being performed (or whether an arterial puncture or renal angiogram was done.”